Literature DB >> 1380405

Ca2+/calmodulin-regulated nitric oxide synthases.

H H Schmidt1, J S Pollock, M Nakane, U Förstermann, F Murad.   

Abstract

NO synthase (NOS) catalyzes the oxidation of L-arginine to L-citrulline and nitric oxide (NO) or a NO-releasing compound. At least three isoforms of NOS exist (types I-III). The activities of the type I isoform purified from brain and the type III isoform purified from endothelial cells are regulated by the intracellular free calcium concentration ([Ca2+]i) and the Ca(2+)-binding protein calmodulin. At resting [Ca2+]i, both isozymes are inactive; they become fully active at [Ca2+]i greater than or equal to 500 nM Ca2+. Longer lasting increases in [Ca2+]i may downregulate NO formation, for in vitro phosphorylation by Ca2+/calmodulin protein kinase II decreases the Vmax of NOS. Besides the conversion of L-arginine, type I NOS, Ca2+/calmodulin dependently, generates H2O2 and reduces cytochrome c/P450. Other redox activities, i.e. the reduction of nitroblue tetrazolium to diformazan (NADPH-diaphorase) or of quinoid-dihydrobiopterin to tetrahydrobiopterin, by NOS appear to be Ca2+/calmodulin-independent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380405     DOI: 10.1016/0143-4160(92)90055-w

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  33 in total

Review 1.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Light responses and morphology of bNOS-immunoreactive neurons in the mouse retina.

Authors:  Ji-Jie Pang; Fan Gao; Samuel M Wu
Journal:  J Comp Neurol       Date:  2010-07-01       Impact factor: 3.215

3.  Rate, affinity and calcium dependence of nitric oxide synthase isoform binding to the primary physiological regulator calmodulin.

Authors:  Jonathan L McMurry; Carol A Chrestensen; Israel M Scott; Elijah W Lee; Aaron M Rahn; Allan M Johansen; Brian J Forsberg; Kyle D Harris; John C Salerno
Journal:  FEBS J       Date:  2011-11-11       Impact factor: 5.542

4.  Modulation of endothelial nitric oxide synthase by fibronectin.

Authors:  R I Viji; V B Sameer Kumar; M S Kiran; P R Sudhakaran
Journal:  Mol Cell Biochem       Date:  2008-12-04       Impact factor: 3.396

5.  Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activation.

Authors:  Marcela Herrera; Jeffrey L Garvin
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

6.  Electron microscopic localization of nitric oxide I synthase in the organ of Corti of the guinea pig.

Authors:  U R Heinrich; J Maurer; K Gosepath; W Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

7.  Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1.

Authors:  Yong P Hwang; Hye G Jeong
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

8.  Characteristics of nitric oxide-mediated cholinergic modulation of calcium current in rabbit sino-atrial node.

Authors:  X Han; L Kobzik; D Severson; Y Shimoni
Journal:  J Physiol       Date:  1998-06-15       Impact factor: 5.182

9.  Action of thiazide on renal interstitial calcium.

Authors:  Shaleka L Eley; Crystal M Allen; Cicely L Williams; Richard D Bukoski; Mildred A Pointer
Journal:  Am J Hypertens       Date:  2008-05-01       Impact factor: 2.689

10.  NMDA receptor-mediated refinement of a transient retinotectal projection during development requires nitric oxide.

Authors:  A F Ernst; H H Wu; E E El-Fakahany; S C McLoon
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.